Clinical Trial Update: Trial of Atezolizumab, Bevacizumab, and Tiragolumab in Patients With Microsatellite Stable, Metastatic Colorectal Cancer [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update of atezolizumab, bevacizumab, and tiragolumab for microsatellite stable metastatic colorectal cancer; the study is currently activ…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer

Drugs mentioned

• Atezolizumab (atezolizumab)
• Bevacizumab (bevacizumab)
• Tiragolumab (tiragolumab)

Snippet

Sponsor: University of Colorado, Denver | Conditions: Microsatellite Stable (MSS) Colorectal Cancer (CRC), Metastatic Colorectal Cancer (CRC) | Phase 2 | Status: ACTIVE_NOT_RECRUITING